The Overwhelming Argument for Rescheduling Psilocybin to Schedule 2 in the Misuse of Drugs Regulations 2001.

  In July, the Conservative Drug Policy Reform Group (‘CDPRG’) produced the most compelling argument (so far) for rescheduling of psilocybin.[1]  It is now time to: Assess the impact of that argument contained in the CDPRG’s report: “Medicinal use of psilocybin: Reducing restrictions on research and treatment” (the ‘Medicinal Use Report’); and Restate and emphasise … Continued